This is a top view of a cylindrical fibrin hydrogel. By design, the right side of the hydrogel contains immobilized Delta-1 proteins, which activate Notch signaling pathways within cells. The left side does not contain immobilized Delta-1 (see insert). The team introduced human bone cancer cells, which were engineered to glow when their Notch signaling pathways are activated, into the hydrogel. The right side of the hydrogel glows brightly, indicating that cells in that region have activated their Notch signaling pathways. Cells on the left side of the hydrogel have not. Scale bar is 1 millimeter.